Kestra Medical Technologies, Ltd
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
59.3M
on 2026-07-31, from 51.3M on 2025-04-30 10-Q ↗
Counts before 2025-04-30 are left out: the count went from 100 on 2025-01-31 to 51.3M on 2025-04-30, a change no split on file explains.
a raise that quarter, at its price
Newest
No limit
S-3ASR of 2026-04-01. An automatic shelf: the form sets no dollar limit. None sold under it to 2026-10-05. S-3ASR ↗
None
No at-the-market programme on file in the last 30 months.
Warrants
No warrant count read from a 10-Q or 10-K.
Cash
9.1 quarters
$198.9M on 2026-07-31 ÷ $21.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-12-02 | Public offering | not read | $23.00 | $138.0M | 424B4 ↗ |
| 2025-03-05 | Public offering | not read | $17.00 | $202.0M | 424B4 ↗ |
Also on file: up to $75.0M term loan agreed 2026-07-10 8-K ↗